Gene Sequencing Center.
Illumina NextSeq 500 Sequencing System
The Gene Sequencing Center at Research Park iNOVA offers access to a NextSeq 500 Sequencing System.
The NextSeq 500 Sequencing System delivers the power of high-throughput sequencing with the speed, simplicity, and affordability of a desktop NGS (next-generation sequencing) system. The fast, integrated, sample-to-results workflow enables many sequencing applications—including exomes, whole genomes, and transcriptomes—in a single run. This NGS system fits seamlessly into research laboratories, with no need for specialized equipment. Now, researchers can perform any combination of high- and mid-throughput sequencing applications to advance their studies.
Description
- NextSeq 500 Sequencing System
- Support
- Downloads
- Training
- Illumina Experiment Manager (program used to create sample sheets)
- Sequencing Analysis Viewer (program used to control data quality)
Owned and operated by
The Faroese Business Development Fund (Vinnuframi)
Illumina MiSeq Sequencer
The Gene Sequecing Center in Research Park iNOVA offers access to a MiSeq Sequencer.
The MiSeq desktop sequencer allows you to access more focused applications such as targeted gene sequencing, metagenomics, small genome sequencing, targeted gene expression, amplicon sequencing, and HLA typing. New MiSeq reagents enable up to 15 Gb of output with 25 M sequencing reads and 2x300 bp read lengths.
Description
- Illumina MiSeq Sequencer
- Support
- Downloads
- Training
- Illumina Experiment Manager (program used to create sample sheets)
- Sequencing Analysis Viewer (program used to control data quality)
Owned and operated by
The Faroese Business Development Fund (Vinnuframi)
ABI 3130xl Genetic Analyser
The fully automated 16-capillary 3130xl Genetic Analyser from Applied Biosystems is a fluorescence-based capillary electrophoresis (CE) system. The system delivers high data quality, fast turnaround times and great reliability across the complete range of sequencing, resequencing (mutational profiling), and fragment analysis applications.
Description
Owned and operated by
P/F Fiskaaling
Agilent 2100 Bioanalyzer system
The Agilent 2100 Bioanalyzer system provides sizing, quantitation and quality control of DNA, RNA, proteins and cells on a single platform, providing high quality digital data.
- Two assay principles - electrophoresis and flow cytometry
- Ready-to-use assays and pre-packaged reagent kits
- Minimal sample consumption (1-4 µL)
- Easy to use – load the chip, press "start", the instrument does the rest!
- Digital data for convenient analysis, archiving and storage
- Contamination-free switch of methods
Description
Owned and operated by
The Faroese Business Development Fund (Vinnuframi)
Covaris M220 Focused Ultrasonicator
DNA Shearing for Next-Generation Sequencing
- Proven Covaris AFA shearing process, as used in genome centers worldwide
- Generates tight, highly reproducible fragment distributions
- Optimized shearing programs to generate fragment sizes between 150 and 5,000 bp
- Also effective for low-mass, high epitope recovery chromatin shearing
- Now the "Scientist’s Standard” is in a low-cost, compact, easy to use design
The M220 Focused-ultrasonicator™ is designed for Next-Gen Sequencing applications requiring fragment sizes between 150bp and 5kb. Compact size and ease-of-use make the M220 Focused-ultrasonicator the ideal DNA shearing solution for MiSeq™ and PGM™ users.
The M220 runs a variety of DNA shearing protocols with Covaris SonoLab 7 software and uses both the Covaris microTUBE™ & miniTUBE™.
Integrated temperature control within the M220 eliminates the need for an external chiller, saving space and cost.
Covaris AFA (Adaptive Focused Acoustics™) transmits acoustic energy at ultrasonic frequencies (>400KHz) and very short wavelengths (~3mm) and is uniquely able to focus the energy into your sample. AFA controls the shearing forces that fragment nucleic acids to the selected size. The process is isothermal, non contact, and quiet.
Covaris AFA technology in the M220 eliminates operator induced variations, improves recoveries, increases efficiency, and provides standardized results.
Description
Owned and operated by
The Faroese Business Development Fund (Vinnuframi)